Immupharma Share Price | |
---|---|
Price | 6.00 |
Bid | 5.62 |
Ask | 5.96 |
Change | 0.30 (5.26%) |
Volume | 456,083 |
Open | 5.60 |
High | 6.00 |
Low | 5.60 |
Prev. Close | 6.00 |
Currency | GBX |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 285m |
Market Capitalisation | £17m |
Market Size | 50,000 |
52 Week High | 10.60 |
52 Week High Date | 12-Aug-2021 |
52 Week Low | 4.80 |
52 Week Low Date | 06-Dec-2021 |
# Trades | 32 |
---|---|
Vol. Sold | 245,441 |
Sold Value | £13,851.55 |
Vol. Bought | 210,642 |
Bought Value | £12,315.91 |
PE Ratio | -1.846 |
Earnings | -3.25 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
27-May-22 | 16:35:20 | 6.00 | 13,500 | Buy* | 5.62 | 6.00 | 810.00 | UT Uncrossing Trade |
27-May-22 | 16:24:25 | 5.80 | 10,000 | Buy* | 5.64 | 5.96 | 580.00 | A Automatic Execution |
27-May-22 | 15:34:20 | 5.648 | 16,221 | Sell* | 5.64 | 5.80 | 916.16 | O Ordinary |
27-May-22 | 15:26:58 | 5.6501 | 83,672 | Sell* | 5.64 | 5.76 | 4,728 | O Ordinary |
27-May-22 | 15:14:10 | 5.6501 | 14,984 | Sell* | 5.64 | 5.80 | 846.61 | O Ordinary |
27-May-22 | 15:13:22 | 5.64 | 34 | Sell* | 5.64 | 5.80 | 1.92 | O Ordinary |
27-May-22 | 14:45:34 | 5.6815 | 17,496 | Buy* | 5.62 | 5.70 | 994.04 | O Ordinary |
27-May-22 | 14:00:56 | 5.61801 | 9,000 | Sell* | 5.60 | 5.78 | 505.62 | O Ordinary |
27-May-22 | 13:53:30 | 5.6181 | 11,000 | Sell* | 5.60 | 5.78 | 617.99 | O Ordinary |
27-May-22 | 12:06:34 | 5.637 | 9,981 | Sell* | 5.62 | 5.96 | 562.63 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
24-Aug-21 | 23-Aug-21 | Buy | Timothy Paul McCarthy held the position of CEO at the time of this trade. Timothy Paul McCarthy | 8.26 | GBX | 250,000 | 288,462 |
24-Aug-21 | 24-Aug-21 | Buy | Tim Franklin held the position of Chief Operating Officer at the time of this trade. Tim Franklin | 8.26 | GBX | 125,000 | 125,000 |
24-Aug-21 | 24-Aug-21 | Buy | Sanjeev Pandya held the position of Senior Independent Non-Executive Director at the time of this trade. Sanjeev Pandya | 8.26 | GBX | 125,000 | 125,000 |
02-Apr-20 | 02-Apr-20 | Notification of Holding | Robert Zimmer held the position of Chief Scientific Officer at the time of this trade. Robert Zimmer | 0.00 | 0 | 27,344,514 | |
02-Apr-20 | 02-Apr-20 | Notification of Holding | Robert Zimmer held the position of Chief Scientific Officer at the time of this trade. Robert Zimmer | 0.00 | 0 | 27,344,514 |